Cargando…

Radiotherapy in Combination with Systemic Therapy for Multiple Myeloma—A Critical Toxicity Evaluation in the Modern Treatment Era

SIMPLE SUMMARY: Radiotherapy is essential for the management of symptomatic osteolytic lesions in multiple myeloma but usually requires a combination with systemic therapy. This study analyzes the acute toxicities of radiotherapy in this setting and demonstrates the feasibility of modern combined mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oertel, Michael, Schlusemann, Tom, Shumilov, Evgenii, Reinartz, Gabriele, Bremer, Anne, Rehn, Stephan, Lenz, Georg, Khandanpour, Cyrus, Eich, Hans Theodor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251922/ https://www.ncbi.nlm.nih.gov/pubmed/37296874 http://dx.doi.org/10.3390/cancers15112909

Ejemplares similares

Radiotherapy in Follicular Lymphoma Staged by (18)F-FDG-PET/CT: A German Monocenter Study
por: Karsten, Imke E., et al.
Publicado: (2021)

Biophysical Analysis of Acute and Late Toxicity of Radiotherapy in Gastric Marginal Zone Lymphoma—Impact of Radiation Dose and Planning Target Volume
por: Reinartz, Gabriele, et al.
Publicado: (2021)

Development of Organ-Preserving Radiation Therapy in Gastric Marginal Zone Lymphoma
por: Rolf, Daniel, et al.
Publicado: (2022)

Combination Treatment Targeting mTOR and MAPK Pathways Has Synergistic Activity in Multiple Myeloma
por: Sun, Kaiyan, et al.
Publicado: (2023)

Long-Term Survival of Patients with Mantle Cell Lymphoma after Total Body Irradiation, High-Dose Chemotherapy and Stem Cell Transplantation: A Monocenter Study
por: Kröger, Kai, et al.
Publicado: (2023)

The Role of Clonal Evolution on Progression, Blood Parameters, and Response to Therapy in Multiple Myeloma
por: Sandmann, Sarah, et al.
Publicado: (2022)

The Burden of Survivorship on Hematological Patients—Long-Term Analysis of Toxicities after Total Body Irradiation and Allogeneic Stem Cell Transplantation
por: Oertel, Michael, et al.
Publicado: (2021)

Characterization and dynamics of the soluble immunological microenvironment in melanoma patients undergoing radiotherapy
por: Oertel, Michael, et al.
Publicado: (2022)

Worth a local treatment? – Analysis of modern radiotherapy concepts for oligometastatic prostate cancer
por: Oertel, M., et al.
Publicado: (2018)

Efficacy and Tolerance of IMRT Boost Compared to IORT Boost in Early Breast Cancer: A German Monocenter Study
por: Schumacher, Luisa, et al.
Publicado: (2022)

Hybrid volumetric modulated arc therapy for hypofractionated radiotherapy of breast cancer: a treatment planning study
por: Venjakob, Alexander, et al.
Publicado: (2020)

Impact of radiation dose on local control and survival in extramedullary head and neck plasmacytoma
por: Oertel, Michael, et al.
Publicado: (2019)

The Safety Profile of Concurrent Therapy for Multiple Myeloma in the Modern Era
por: Resende Salgado, Lucas, et al.
Publicado: (2018)

Bridging vor CAR T-Zell-Therapie – eine neue Indikation der Strahlentherapie?
por: Oertel, Michael, et al.
Publicado: (2021)

Strahlentherapeutische Behandlung von Leukämien
por: Oertel, Michael, et al.
Publicado: (2022)

Strahlentherapeutische Behandlung von Leukämien
por: Oertel, Michael, et al.
Publicado: (2022)

Kardiovaskuläre Risikoevaluation in der Behandlung des Hodgkin-Lymphoms – auf dem Weg zur individualisierten Planung?
por: Oertel, Michael, et al.
Publicado: (2023)

Radiotherapie kutaner Lymphome
por: Rolf, Daniel, et al.
Publicado: (2022)

Palliative care on the radiation oncology ward—improvements in clinical care through interdisciplinary ward rounds
por: Oertel, Michael, et al.
Publicado: (2022)

Impact of radiation techniques on lung toxicity in patients with mediastinal Hodgkin’s lymphoma
por: Pepper, Niklas Benedikt, et al.
Publicado: (2020)

Role of radiotherapy in extracranial metastatic malignant melanoma in the modern era
por: Youland, Ryan S., et al.
Publicado: (2017)

Limited recurrence distance of glioblastoma under modern radiotherapy era
por: Tu, Ziwei, et al.
Publicado: (2021)

Advancements of radiotherapy for recurrent head and neck cancer in modern era
por: Zhang, Shu, et al.
Publicado: (2023)

CAR-T Cell Therapy Shows Similar Efficacy and Toxicity in Patients With DLBCL Regardless of CNS Involvement
por: Shumilov, Evgenii, et al.
Publicado: (2023)

Prevalence of the GFI1-36N SNP in Multiple Myeloma Patients and Its Impact on the Prognosis
por: Khandanpour, Cyrus, et al.
Publicado: (2021)

The new German evidence-based guideline on diffuse large B-cell lymphoma—key aspects for radiation oncologists
por: Oertel, Michael, et al.
Publicado: (2023)

Sekundärmalignome nach Ganzkörperbestrahlung pädiatrischer Leukämiepatienten – eine kritische Re-Evaluation der multizentrischen ALL-SCT-BFM-2003-Studie
por: Knaack, Christian, et al.
Publicado: (2023)

A treatment planning study comparing IMRT techniques and cyber knife for stereotactic body radiotherapy of low-risk prostate carcinoma
por: Scobioala, Sergiu, et al.
Publicado: (2019)

Long-term survival and polyclonal immunoglobulin reconstitution after allogeneic stem cell transplantation in multiple myeloma
por: Eisfeld, Christine, et al.
Publicado: (2020)

Radiation Therapy in the German Hodgkin Study Group HD 16 and HD 17 Trials: Quality Assurance and Dosimetric Analysis for Hodgkin Lymphoma in the Modern Era
por: Oertel, Michael, et al.
Publicado: (2022)

Pulmonary Toxicity after Total Body Irradiation—An Underrated Complication? Estimation of Risk via Normal Tissue Complication Probability Calculations and Correlation with Clinical Data
por: Oertel, Michael, et al.
Publicado: (2021)

Minimising the Toxicities of First Line Hodgkin Lymphoma Treatment in the Modern Era
por: Follows, Annabel M., et al.
Publicado: (2022)

Multidisciplinary Management of Radiation-Induced Salivary Gland Carcinomas in the Modern Radiotherapy Era
por: Romanello, Domenico Attilio, et al.
Publicado: (2020)

Treatment of Multiple Myeloma and the Role of Melphalan in the Era of Modern Therapies—Current Research and Clinical Approaches
por: Poczta, Anastazja, et al.
Publicado: (2021)

Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicine
por: Shimazu, Yutaka, et al.
Publicado: (2021)

Gfi1 as a regulator of p53 and a therapeutic target for ALL
por: Khandanpour, Cyrus, et al.
Publicado: (2013)

Role of GFI1 in Epigenetic Regulation of MDS and AML Pathogenesis: Mechanisms and Therapeutic Implications
por: Möröy, Tarik, et al.
Publicado: (2019)

Editorial: New emerging functions of transcription factors and RNA-binding proteins in the development of hematological malignancies
por: Möröy, Tarik, et al.
Publicado: (2023)

Clinical Outcome of Palliative Radiotherapy for Locally Advanced Symptomatic Gastric Cancer in the Modern Era
por: Tey, Jeremy, et al.
Publicado: (2014)

The Risk of Second Primary Cancers in Prostate Cancer Survivors Treated in the Modern Radiotherapy Era
por: Jahreiß, Marie-Christina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9f7apast6k04a4fkhgkbbedtrb